RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$926M
AUM Growth
+$212M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1
+$17.7M
2
+$9.4M
3
+$8.18M
4
XLRN
Acceleron Pharma
XLRN
+$8.1M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.8M

Top Sells

1
+$13.9M
2
+$9.07M
3
+$8.61M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$6.71M
5
NKTR icon
Nektar Therapeutics
NKTR
+$6.6M

Sector Composition

1 Healthcare 94.86%
2 Communication Services 1.03%
3 Energy 0.07%
4 Technology 0.06%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.84M 0.31%
+60,000
77
$2.7M 0.29%
37,000
-1,000
78
$2.57M 0.28%
144,604
79
$1.82M 0.2%
40,466
-25,332
80
$1.74M 0.19%
775,000
-75,000
81
$930K 0.1%
3,750
82
$265K 0.03%
2,974
83
$241K 0.03%
5,388
84
$217K 0.02%
+2,381
85
$192K 0.02%
1,660
-657
86
$183K 0.02%
8,645
-2,000
87
$177K 0.02%
29,164
88
$162K 0.02%
+1,723
89
$149K 0.02%
+1,338
90
$147K 0.02%
+4,751
91
$138K 0.01%
+2,806
92
$137K 0.01%
+6,926
93
$135K 0.01%
+5,272
94
$108K 0.01%
+8,299
95
– –
-50,000
96
– –
-200,000
97
– –
-20,000
98
– –
-40,000
99
– –
-650,000
1 2 3
4